Roivant Sciences valuation
$39.21Change from previous close: −0.81%Absolute change: −$0.32
Valuation
The average price target of 11 analysts is $50.82.
Data as of November 16, 2026
Roivant Sciences compared with similar companies
Roivant Sciences's Price/book: 7.12, in line with the median of a group of 11 similar companies (7.20).
| Metric | Roivant Sciences | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| Price/book | 7.12 | 7.20 | 4.45 – 9.96 | Middle |
| Gross margin | 0.0% | 84.4% | 66.4% – 91.5% | Low |
| Operating margin | -3,226.3% | 19.5% | -48.6% – 31.6% | Low |
| Net margin | 0.0% | 6.7% | 0.0% – 30.6% | Middle |
| ROE | -8.5% | 7.8% | -8.3% – 31.4% | Low |
| Debt/equity | 0.02 | 0.35 | 0.06 – 0.85 | Low |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Other metrics
Valuation multiples
- Market cap
- $28.64B
- Enterprise value
- $25.12B
- P/E (trailing 12 months)
- -74.9
- Forward P/E
- -24.5
- Price/sales
- 697.2
- EV/EBITDA
- -19.0
- EV/revenue
- 611.4
Profitability and growth
- ROA
- -16.5%
- ROIC
- -16.9%
- Revenue growth (year over year)
- 2,135.6%
- Earnings growth (year over year)
- -19.8%
Financial health
- Total cash
- $4.21B
- Total debt
- $106.57M
- Current ratio
- 15.6
- Quick ratio
- 15.1
- Altman Z-Score
- 31.1
- Piotroski F-Score
- 3.00
Dividends
- Dividend yield
- 0.0%
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $50.82
- Median price target
- $51.00
- High price target
- $62.00
- Low price target
- $42.00
- Analysts with a price target
- 11
- Consensus
- Strong buy
- Forward EPS
- -$1.61
- EPS estimate, current year
- -$1.12
Shares and trading
- Beta
- 1.20
- Average volume
- 8.12M
- Shares outstanding
- 724.56M
- Float
- 572.71M
- Institutional ownership
- 80.9%
- Insider ownership
- 23.1%
- Short interest (% of float)
- 8.5%
- Short ratio (days)
- 7.15
